drugs
vaccines
Lyme-disease vaccine
Lyme disease
infection
vaccine
vaccine
spirochete
spiral-shaped bacterium
Borrelia burgdorferi
bullseye rash
facial palsy
joint pain
arthritis
antibiotics
treatment-resistant Lyme arthritis
Lyme disease
Lyme disease
antibodies
Borrelia
antibiotic treatment
Lyme disease
neurological problems
Lyme disease
Borrelia
etiologic agents
erythema chronicum migrans
ECM
Lyme disease
LD
acrodermatitis chronica atrophicans
ACA
lymphadenosis benigna cutis
(LBC
Spiegler-Fendt sarcoid
morphea
lichen sclerosus et atrophicus
LSA
progressive facial hemiatrophyofParry-Romberg
PFH
benign lymphocytic infiltrate of the skin
BLI
Shulman syndrome
eosinophilic fasciitis
Lyme disease
ACA
LBC
LSA
PFH
BLI
Shulman syndrome
borreliae
Lyme disease
syphilis
endemic area
primary and secondary disease
erythema migrans
erythema migrans
Clinical manifestations of nonspecific inflammation
arthralgia
monoarticular arthritis
polyarticular arthritis
Indirect fluorescent antibody testing
IgM
IgG antibodies
Antibacterial therapy
Jarisch-Herxheimer
Lyme disease
Ixodes genus
skin
I. scapularis
ED
endemic areas
LD
I. scapularis
pathology identification
Ixodes ticks
LD
Lyme disease
B. burgdorferi
human monocytic ehrlichiosis
Ehrlichia chaffeensis
human granulocytic ehrlichiosis
Ehrlichia phagocytophila
Rickettsia rickettsii
murine typhus
Rickettsia typhi
Q fever
Coxiella burneti
tularaemia
Francisella tularensis
babesiosis
Babesia microti
IgG antibodies
E. phagocytophila
R. rickettsii
R. typhi
C. burneti
B. microti
indirect fluorescent antibody assays
IFA
F. tularensis
agglutination assay
IgG antibodies
Lyme disease
spirochaete
enzyme-linked immunosorbent assay
ELISA
antigens
Hanks' balanced salt solution
HBSS
HBSS
N40 strain of B. burgdorferi sensu stricto
spirochaetes
spirochaetes
antigen
antibody
alkaline phosphatase-conjugated goat antihuman IgG
p-nitrophenyl phosphate substrate in diethanolamine buffer
secondary antibody
Lyme disease
Serum samples
serum sample
Rocky Mountain spotted fever
antigens of E. chaffeensis
Lyme arthritis
monoarticular and oligoarticular arthritis
Lyme disease
skin
nervous system
heart
joints
antibiotic therapy
Lyme arthritis
Lyme disease
arthritis
Lyme disease spirochete
nymphal Ixodes scapularis ticks
Lyme arthritis
Borrelia burgdorferi
B. burgdorferi
OspC type A
RST1
Lyme disease epidemic
Lyme arthritis
serologic testing
Lyme arthritis
Lyme arthritis
reactive arthritis
pauciarticular juvenile idiopathic arthritis
serologic testing
Lyme arthritis
acute septic arthritis
Lyme arthritis
Lyme arthritis
septic bacterial arthritis
symmetrical polyarthritis
Lyme arthritis
rheumatoid arthritis
Fibromyalgia
Lyme disease
fibromyalgia
rheumatoid arthritis
reactive arthritis
psoriatic arthritis
Lyme disease
spirochetal infection
endemic areas
Lyme disease
antibody
B. burgdorferi
antibiotic-treated Lyme arthritis
synovial WBC counts
Lyme arthritis
inflammatory arthritides
antibiotic therapy
Lyme arthritis
oral antibiotics
oral antibiotic
oral antibiotics
IV ceftriaxone
antibiotics
IV therapy
antibiotic
oral doxycycline
IV therapy
persistent joint inflammation
synovitis
IV therapy
synovial tissue hypertrophy
IV antibiotics
oral amoxicillin therapy
IV ceftriaxone
antibiotics
daptomycin
carbomycin
cefoperazone
spirochetes
antibiotics
Lyme arthritis
late manifestation of Lyme disease
erythema migrans
two-tier serologic testing
B. burgdorferi
ELISA
IgG Western blotting
spirochetal proteins
PCR testing
B. burgdorferi DNA
antibiotic therapy
spirochetal DNA
spirochetal eradication following antibiotic treatment
oral doxycycline
amoxicillin
oral therapy
IV ceftriaxone
oral and IV antibiotic therapy,
anti-inflammatory agents
DMARDs
synovectomy
antibody
B. burgdorferi
LM
Lyme disease
erythema migrans
serologic diagnosis
Lyme-serology results
Lyme disease
Lyme disease
AM
Lyme serology
CSF red blood cell count
CSF WBC
CSF WBC differential
CSF bacterial culture
CSF viral culture
CSF enterovirus PCR
Lyme serology
CSF bacterial and viral cultures
enterovirus CSF PCR testing
Neuroimaging
Lyme disease
Single-photon emission computed tomography scans
cortex
subcortical white matter
magnetic resonance imaging scans
single-photon emission computed tomography scans
white matter lesions
enlarged ventricles
cortical atrophy
spirochete
brain territories
Neuropsychologic testing
Electroencephalograms
Lyme disease
encephalitis
Cerebrospinal fluid
CSF
Lyme antibodies
Lyme disease
nervous system
CSF antibodies
serologic antibodies
Lyme disease
CSF antibody test
central nervous system Lyme disease
CSF antibody test
Lyme disease
CSF
Lyme disease syndrome
Lyme disease
persistent Lyme infection
Lyme disease
serologic testing
Lyme disease
Lyme disease
antimicrobials
EM
oral doxycycline
amoxicillin
cefuroxime axetil
Lyme disease
oral or intravenous antimicrobials
Lyme disease
skin
doxycycline
Lyme disease
I. scapularis
I. pacificus tick
B. burgdorferi
prophylactic antibiotic
repellent system
personal protective measure
PPM
arthropod borne infections
arthropod-related disease
PPM guidelines
PPM guidelines
PPM guidelines
ACIP Lyme disease vaccine
epidemiological data
Lyme disease infection
seroepidemiology
pathogen
Borrelia burgdorferi
Bb
spirochete family
spirochete
central protoplasmic cylinder
periplasmic flagella
outer cell membrane
carbohydrate-containing slime layer
Bb
chromosomal DNA
extrachromosomal double-stranded DNA
supercoiled circular and linear plasmids
plasmid DNA code
Bb
p41
p58-60
p66
p68
p71
p73
heat-shock proteins
borrelia proteins
serological cross-reactivity
outer surface lipoproteins
Osp
OspA
OspB
OspC
OspD
OspE
OspF
p93
protoplasmic cylinder antigen
p39
lipoprotein
Facial nerve palsy
Facial nerve palsy
FNP
Lyme disease
Lyme disease-associated FNP
EM
EM
FNP
Lyme disease-associated FNP
Lyme neuroborreliosis
FNP
endemic areas
FNP
neuroborreliosis
CSF Bb-specific IgM antibodies
Lyme disease-associated FNP
Aseptic meningitis
EM
FNP
Lyme meningitis
meningitis
headache
neck stiffness
fever
CSF cell count
meningitis
endemic area
Lyme disease
CSF anti-B
burgdorferi antibodies
Facial nerve palsy
Lyme-associated facial nerve palsy
diopathic Bell's palsy
EM
Lyme disease
endemic area
Anti-B. burgdorferi antibody
CSF
occult meningitis
serological studies
Optic nerve edema
optic neuritis
Lyme disease
EM
optic neuritis
optic nerve edema
Lyme disease
LD
spirochete Borrelia burgdorferi
LD
erythema migrans
EM
Rheumatologic
neurologic
dermatologic
cardiologic
LD
LD
neurologic syndromes
LD
acute myositis
chronic encephalopathy
facial palsy
aseptic meningitis
neuroborreliosis
Lyme serology
systemic LD
oral spirochetes
asymptomatic seroconversion
pathogens
LD
neuroborreliosis
LD
seropositive
seropositive
neuroborreliosis
Lyme serology
Lyme disease
oligoarticular inflammatory arthritis
bursitis
tendinitis
temporomandibular joint pain
acute arthritis
SF white blood cell counts
septic arthritis
Lyme arthritis
systemic infection
joint effusion
Baker’s cysts
antibiotic treatment
Lyme arthritis
synovitis
synovitis
antibiotics
antibiotic-refractory Lyme arthritis
B burgdorferi
nonseptic inflammatory arthritis
Lyme arthritis
oral antibiotics
Nonsteroidal antiinflammatory drugs
antibiotic treatment
antibiotics
intraarticular corticosteroids
oral antibiotics
intravenous antibiotics
PCR testing
SF
borrelia DNA
Antibiotic-refractory Lyme arthritis
intraarticular steroids
DMARD therapies
TNF antagonists
Synovectomy
synovial tissue
synovial tissue
B burgdorferi
Lyme disease
antibiotic therapy
B burgdorferi
EM lesions
EM
EM
Posttreatment Lyme disease syndrome
PTLDS
PTLDS
PTLDS
chronic Lyme disease
Systemic inflammatory cytokines
central nervous system infection
Spirochetes
protein profile
Ixodes ricinus ticks
antigenic determinants
Ixodes pacificus ticks
Ixodes persulcatus ticks
Lyme disease
Bb sensu stricto,
Borrelia afzelii
Borrelia garinii
B. burgdorferi sensu lato complex
Borrelia spp
Borrelia spielmanii
Borrelia bavariensis
Borrelia bissettii
Borrelia lusitaniae
Borrelia americana
Borrelia andersonii
Borrelia valaisiana
Bb
Lyme disease
B. americana
B. andersonii
blood
skin
EM
Lyme disease
B. bissettii
cerebral spinal fluid
CSF
Lyme disease
PCR
PCR
Borrelia
PCR
tissue samples
culture-based typing
Lyme disease
primary lesion
Borrelia inoculation
erythema migrans
erythematous papule
plaque
EM
fever
malaise
headache
skin lesion
pruritus
regional lymphadenopathy
EM
Lyme disease
spirochetes
secondary lesions
Borrelia infection
EM lesions
erythematous plaques
lesion
Lyme neuroborreliosis
LNB
carditis
skin lesion
borrelial lymphocytoma
tertiary skin lesion
Borreliawas
acrodermatitis chronic atrophicans
atrophic skin
Acordermatitis chronica atrophicans
ACA
LA
EM
arthralgias
myalgias
EM
antibiotics
LA
EM
EM
Lyme disease
LA
EM
vaccine trial
Bb infection
systemic symptoms
arthralgias
headaches
Lyme disease
asymptomatic seroconversion
LA
Lyme disease
LA
Lyme disease
LA
LA
Lyme borreliosis
LA
Lyme disease
LA
Lyme disease
antibiotics
antibiotics
Borrelia spirochetes
b-lactams
tetracyclines
macrolides
Borrelia
antibiotics
Lyme disease
randomized controlled trials
RCTs
Lyme disease
RCTs
doxycycline
EM
amoxicillin
RCT
Lyme borreliosis
amoxicillin
ceftriaxone
infecting species
Borrelia spp.
CSF samples
synovial fluid
tissue samples
PCR-based amplification of DNA
tissue specimens
PCR target
CSF
Borrelia spp.
EM
antibiotics
Borrelia
extracutaneous lesions
EM lesions
Borrelia
Borrelia spp.
B. garinii
CSF
B. afzelii infection
nervous system
LNB
B. garinii infection
radiculoneuritis
peripheral facial palsy
B. afzelii
CSF
CSF B. afzelii
LNB
Histopathology
peripheral nerve biopsy specimens
Lyme disease
lymphocytes
plasma cells
histiocytes
patchy multifocal axonal degeneration
lymphocytic infiltrate
meninges
white and gray matter
dorsal root ganglia
nerve roots
immune cells
inflammatory and neurotoxic substances
T-cell lines
CSF
LNB
type 1 cytokine pattern
IFNg
IL-4
CSF mononuclear cells
MNC
LNB
borrelial antigens
IFNgsecreting cells
peripheral blood
responder cells
IFNg
cytokines
chemokines
CSF
LNB
IFNg
CSF
CD8þ T cells
nerve biopsy samples
ACA-associated polyneuropathy
CD8 T cells
CSF
acute LNB
TNFa
IFNg
Borrelia antigens
Borrelia-specific CD8þ T cells
LNB
Borrelia infection
peripheral CD8þ
gd T cells
Borrelia-specific IFNg
chronic Lyme borreliosis
CSF
immune response
T cell
infection
erythema migrans lesions
musculoskeletal
neurologic
cardiovascular symptoms
Musculoskeletal symptoms
migratory joint
muscle pain
joint swelling
Neurologic manifestations
meningitis
facial cranial nerve
radicular neuropathies
Cardiovascular symptoms
temporary atrioventricular blocks
cardiac involvement
heart block
Lyme disease
B burgdorferi
endemic
B burgdorferi
spirochetes
salivary glands
antibiotic prophylaxis
Ixodes tick
endemic area
B burgdorferi
doxycycline
prophylaxis
Lyme disease
Prophylaxis
I pacificus
B burgdorferi
B burgdorferi infection
Ixodes ticks
N,N-di-ethyl-m-toluamide
DEET
skin
acaricides
I scapularis ticks
Lyme disease
Lyme disease
skin
scalp
endemic areas
Lyme disease
Lyme borreliosis
rheumatologist
arthritis
juvenile rheumatoid arthritis
Lyme Arthritis
erythematous annular rash
etiology
bacterial pathogen
rash
penicillin
erythema chronicum migrans
Bannwarth’s syndrome
acrodermatitis chronica atrophicans
pathogen
Borrelia burgdorferfi
I. damimini
I. scapularis
spirochete bacterium
skin lesions
cerebrospinal fluid
Lyme disease
zoonotic infection
B. burgdorferi
obligate parasites
B. burgdorferi species
reservoir animals
spirochetes
reservoir hosts
nymphal stage
Borrelia species
lipoproteins
outer-surface proteins
Osp
A-F
VIsE
surface lipoproteins
spirochetes
protein OspA
OspC
spirochete’s
VIsE
OspC
immune system
VIsE protein
B. burgdorferi
toxins
immunopathologic response
B. burgdorferi
etiologic agents
Treponema pallidum
syphilis
serologic tests
PCR assays
organism-specific nucleic acid
B. burgdorferi
EM skin tissue
blood samples
cerebrospinal
meningitis cases
joint fluids
hematologic
liver profile tests
Lyme disease
Lyme borreliosis’
infectious and non-infectious entities
Lyme disease
B. burgdorferi
Local red skin lesions
B. burgdorferi EM lesions
Localized soft tissue infections
Staphylococcal aureus
methicillin-resistant strains
pyogenic infections
EM
vesicular EM
Herpes simplex
Varicella zoster infections
EM
Lyme disease
fever
malaise
headache
myalgias
pain on neck flexion
regional and localized lymphadenopathy
cranial nerve function
Lyme disease
H. simplex
V. zoster
Lyme arthritis
septic joint
pathogen
synovial fluid
pyogenic infections
S. aureus
reactive arthritis
gastrointestinal and sexually transmitted infections
non-infection inflammatory arthritic processes
Lyme arthritis
juvenile rheumatoid arthritis
Lyme disease
I. scapularis tick
human pathogens
B. burgdorferi
Anaplasma phagocytophilium
Babesia microti
Lyme disease
Human granulocytic anaplasmosis
ehrlichosis
A. phagocytophilium
leukopenia
thrombocytopenia
hepatic amino-transaminases
Lyme disease
rickettsial organism
protozoa B. microti
I. scapularis
infected blood
red blood cell pathogen
hemolytic anemia
maltese cross
erythrocytes
functional or anatomic asplenia
Lyme disease
antimicrobial therapy
Lyme borreliosis
EM lesion
doxycycline
amoxicillin
cefuroxime axetil
Doxycycline
A. phagocytophilium
Macrolide antibiotics
beta-lactam medications
doxycycline
doxycycline
antibiotics
IV
cephalosporin antibiotic
ceftriaxone
B. burgdorferi
oral doxycycline
intravenous ceftriaxone
Lyme disease
neurologic abnormalities
atrioventricular block
intravenous ceftriaxone
oral agent
cardiac pacemaker
AV block
oral agents
Tick-borne diseases
TBD
TBD
pathogens
pathogens
antibiotic prophylaxis
Lyme disease
Lyme disease
tick-bite prophylaxis
prophylactic antibiotic treatment
TBD
Lyme disease
endemic area
myelogram
lumbar puncture
cerebrospinal fluid
CSF
dexamethasone
Decadron
lumbar puncture
LP
CSF samples
glucose
white blood cells
protein levels
CSF
rash
erythematous area
breast
lesion
erythema migrans
LP
CSF
pathogenic Borrelia species
Lyme disease
Lyme disease
Borrelia burgdorferi
Borrelia afzelii
Borrelia garinii
Borrelia burgdorferi
Lyme disease
skin lesion
erythema migrans
spirochete
meningitis
cranial or peripheral neuritis
carditis
atrioventricular node block
migratory musculoskeletal pain
Lyme arthritis
Borrelia infection
synovial fluid
polymorphonuclear and mononuclear cells
Lyme arthritis
oral or intravenous antibiotic therapy
proliferative synovitis
oral antibiotics
intravenous antibiotics
antibiotic-refractory Lyme arthritis
NapA
Bacillus subtilis
NapA gene
polymerase chain reaction
PCR
B burgdorferi strain B31
restriction enzyme sites
fragment
expression vector pSM214G
plasmid pSM214G-NapA
B subtilis strain SMS 118
plasmid pSM214G-NapA
chloramphenicol
supernatant
PCR analysis
RNA
RNA
primers
GAPDH
IL-23p19
IL-12p40
IL-6
TGFβ
IL-1
messenger RNA
mRNA
cytokines
IL-23p19
IL-12p40
IL-6
TGFβ
IL-1β
mRNA
mRNA
GAPDH mRNA
Bacterial meningitis
cerebrospinal fluid
CSF
pleocytosis
bacterial meningitis
Lyme disease
endemic areas
CSF pleocytosis
bacterial meningitis
Lyme meningitis
Borrelia burgdorferi serology results
antibiotics
Lyme meningitis
Lyme meningitis
Lyme serology
Lyme meningitis
aseptic meningitis
Lyme meningitis
Lyme meningitis
headache
cranial neuritis
CSF mononuclear cells
Lyme meningitis
Lyme meningitis
CSF mononuclear cells
cranial nerve palsy
LD
FNP
Fever
headache
Facial nerve palsy
LD
LD
EM
head
neck
EM
FNP
neural invasion
FNP
LD
bilateral FNP
Bilateral FNP
LD
CNS invasion
FNP
LD
peripheral FNP
FNP
LD
Erythrocyte sedimentation rates
Cerebral spinal fluid
CSF
lymphocytosis
proteins
viral meningitis
LD
antibody tests
LD
IgM
IgG
Bilateral lower motor neurone facial weakness
mononeuritis multiplex ring
Lyme disease
unilateral lower motor neurone facial weakness
Bell’s palsy
post-auricular pain
dry eye
Lyme disease
facial palsy
erythema migrans
arthralgia
serological testing
seroconversion
Lyme disease
Bell’s palsy
endemic areas
Lyme disease
right shoulder subacromial impingement
ubacromial bursitis
rotator cuff tendinopathy
supraspinatus tendon
MRI
subacromial impingement
supraspinatus tendinopathy
musculoskeletal diagnosis
physical examination
flu-like symptoms
runny nose
sinus congestion
itchy throat
sinus congestion
supraspinatus impingement
clinical impression of supraspinatus tendinopathy
Palpation examination
supraspinatus tendon
supraspinatus muscle belly
minimal scapular dyskinesia on the right side
manual muscle testing
MMT
Lyme disease
distal supraspinatus tendon
spirochetes
distal supraspinatus tendinopathy
Lyme disease
spirochete load
supraspinatus impingement
Lyme disease
Lyme disease
Lyme disease
pathogen
atypical musculoskeletal conditions
Lyme disease
Lyme disease
acute Lyme disease
PTLDS
Lyme disease
PTLDS
Lyme disease
PTLDS
PTLDS
Lyme disease
PTLDS
PTLDS
PTLDS
PTLDS
Lyme disease
PTLDS
PTLDS
PTLDS
Lyme disease
PTLDS
PTLDS
Lyme disease
PTLDS
Lyme endemic states
endemic states
endemic states
non-endemic states
endemic states
Lyme endemic
non-endemic regions
Lyme disease
Lyme disease
Lyme disease
PTLDS
Lyme disease
PTLDS
Lyme disease
PTLDS
Lyme endemic
non-Lyme endemic groups
Lyme disease
borreliosis results
spirochete Borrelia burgdorferi
Lyme disease
endemic regions
Lyme disease
protean clinical manifestations involving skin
heart
musculoskeletal
nervous systems
Lyme neuroborreliosis
LN
Encephalopathy
behavioral changes
intracranial pressure
sixth nerve palsy
unilateral or bilateral facial paralysis
intranuclear ophthalmoplegia
brainstem dysfunction
lesion
neoplasia
Neurologic manifestations of borreliosis
LN
Lyme meningitis
unilateral facial palsy
antibiotic therapy
Lyme arthritis
headache
optic neuropathy
myelopathy
erythema migrans
oral doxycycline
amoxicillin
oral antibiotics
borrelia
central nervous system
Ceftriaxone
B. burgdorferi
cerebrospinal fluid
synovial fluid
ceftriaxone
Lyme disease
neuroborreliosis
carditis
meningitis
standard oral therapy
parenteral ceftriaxone
B. burgdorferi infection
meningitis
Lyme disease
Lyme borreliosis
Erythema migrans
erythematous skin lesion
Disseminated disease
erythema migrans lesion
carditis manifested by heart block
seventh-cranial-nerve palsy
acute large-joint arthritis
syphilis
meningitis
collagen vascular disease
Lyme disease
gallbladder disease
ceftriaxone
doxycycline
Lyme disease
meningitis
encephalitis
Lyme disease
seventh-cranial-nerve palsy
ceftriaxone group
lumbar puncture
ceftriaxone
large-joint arthritis
palsy
palsy
doxycycline
arthralgia
myalgia
joint swelling
intravenous ceftriaxone
musculoskeletal system
early Lyme disease
highly endemic disease
early Lyme disease
arthritis
arthralgia
neuropathy
cognitive impairment
neurologic,
cardiac
musculoskeletal disorders
arthralgia
fatigue
oral and parenteral antibiotics
early Lyme disease
Mild arthralgia
fatigue
headache
intravenous ceftriaxone
oral penicillin
arthralgia
oral treatment with amoxicillin
probenecid
doxycycline
cefuroxime axetil
doxycycline
mild-to-severe fatigue
arthralgia
myalgia
LNB
chronic persistence
LNB
B. burgdorferi
disease pathogenesis
B. burgdorferi
multiple cycles of antibiotic treatment
biofilmlike protective structure
biofilm
B. burgdorferi
fromamotile
biofilm matrix
B. burgdorferi biofilms
human infected skin tissues
mucopolysaccharides
alginate
extracellular DNA
biofilm
biofilm
Borrelia detection
blood
spirochetes
host immune system
antibiotic therapy
Borrelia sensu latu
B. burgdorferi sensu lato
LB
B. afzelii
B. garinii
common pathogen
B. afzelii
B. garini
B. bavariensis
LB
LNB
B. burgdorferi sensu lato genospecies
LB
B. afzelii
skin infections
B. garinii
neurotropic
B. lusitaniae
B. valaisiana
endemic areas
LNB
B. burgdorferi sensu lato genotype
erythema migrans
B. afzelii
B. garinii
epidemiological and clinical characteristics
erythema migrans
B. garinii
erythema migrans
B. afzelii
OspC
ErpP
ErpA
ErpC
enolase
host plasminogen
spirochetal surface
Plasminogen
glycoprotein
plasminogen to active plasmin
proteolytic activation
tissue-type plasminogen activator
tPA
urokinase-type plasminogen activator urokinase
uPA
Plasmin
intravascular fibrinolysis
tissue remodeling
cell migration
thrombolysis
Invasive forms of B. burgdorferi
plasminogen-binding surface proteins
pathogen dissemination
host tissues
Enolase
integral enzyme of the glycolysis and gluconeogenesis pathways
eukaryotic cells
surface enolase
plasminogen receptor in certain tumor cells
enzyme
B. burgdorferi
surface-localized enolase acts as a plasminogen receptor
plasminogen
spirochetemia
Surface-associated plasmin on B. burgdorferi degrade fibronectin
ECM
laminin
vitronectin
B. burgdorferi
host matrix metalloproteases 9
MMP-9
MMP-1
plasmin-coated B. burgdorferi activates pro-MMP-9
Biofilm production in Borrelia
complex array of signaling processes
spirochetes
RpoN–RpoS alternative sigma factor
LuxS quorumsensing pathways
several cellular functions
pH and temperature variations
high osmolarity
oxidative stress
high cell density
nutrient starvation
host infection
biofilm production in B. burgdorferi
RpoN–RpoS pathway
adaptive changes in B. burgdorferi
tick vector
mammalian host
RpoN–RpoS pathway
activity of RpoN
transcription of RpoS
RpoN-type promoter sequence
σ^{54}-σ^{S} cascade
bacterial enhancer-binding protein
bEBP
σ^{54}-dependent activato
Rrp2
BosR
RpoS
global gene regulator
stress responses
host infection and survival
biofilm formation
biofilm formation
Borrelia to localize intracellularly in the host
chronic or persistent infection
efficacy of antibiotics
extracellularmatrix
antibiotics
LB
Doxycycline
intracellular infections
azithromycin
Mycoplasma
Chlamydia
Legionella
ceftriaxone
Salmonella
Neisseria
amoxicillin
Listeria infections
intracellular localization of Borrelia
chronic bacterial persistence in the host
LNB
Lyme disease
antimicrobial treatment
chronic LNB
persistent forms of Lyme
LB
Persistent Borrelia infection
antimicrobial treatment
antibiotic resistance
LB
biofilm-like aggregates
Borrelia spp.
monotherapy regimens
Lyme Disease
ethidium bromide staining
Southern blot hybridization
PCR-amplified fraction
electrophoresis
nylon membrane by capillary blotting
5x saline-sodium citrate
SSC
2X SSC
Cranial neuropathy
Lyme neuroborreliosis
early neurological involvement
Borrelia burgdorferi sensu lato
cranial nerves
facial nerve paresis
Unilateral or bilateral facial palsy
cranial nerve affection
Lyme neuroborreliosis
facial palsy
Lyme disease-associated facial weakness
meningoradiculoneuritis
Garin-Bujadoux-Bannwarth's syndrome
Facial palsy
Lyme disease
peripheral neuropathy
CSF abnormalities
lymphocytic pleocytosis
plasma cells
CSF protein concentrations
blood-CSF barrier damage
intrathecal Ig production
CSF glial protein marker
glial fibrillary acidic protein
brain parenchyma
early Lyme neuroborreliosis
host
mammalian or avian hosts
host
I. ricinus
life stages
vector-borne disease
tick-borne pathogens
Lyme disease
Lyme disease
spirochetes Borrelia burgdorferi sensu stricto
B. burgdorferi
Borrelia mayonii
Ixodes scapularis
Ixodes dammini
I. scapularis
Lyme disease
I. scapularis-borne diseases
I. scapularis-borne human pathogens
I. scapularis
Anaplasma phagocytophilum
Bo. burgdorferi
Bo. mayonii
Bo. miyamotoi
E. muris eauclarensis
Babesia microt
Powassan virus
I. scapularis-borne pathogens
I. scapularis
important vector of human pathogens
I. scapularis
I. scapularis
I. scapularis
core distribution
Lyme disease
inflammatory arthritis
Bo. burgdorferi
etiological agent
I. scapularis
reservoirs of Bo. burgdorferi
Human granulocytic anaplasmosis
human granulocytic ehrlichiosis
Ehrlichia phagocytophila
acute febrile illnesses
host-seeking activity of I. scapularis and Dermacentor variabilis
Ixodes ricinus
E. phagocytophila
I. scapularis
vector of E. phagocytophila
P. leucopus
intraleukocytic bacterium
A. phagocytophilum
Bo. burgdorferi
Ba. microti
common reservoir
Bo. burgdorferi
Ba. microti
Bo. burgdorferi
A. phagocytophilum
independent enzootic transmission maintenance cycles
I. scapularis
Bo. burgdorferi
A. phagocytophilum
pathogen acquisition
coinfections
coinfection
Bo. burgdorferi
A. phagocytophilum
Ba. microti
Bo. miyamotoi
Lyme disease
anaplasmosis
Powassan virus disease
babesiosis
Lyme disease cases
anaplasmosis
babesiosis
Lyme disease cases
Lyme disease
Bo. miyamotoi disease cases
Lyme disease
ehrlichiosis
E. muris eauclarensis
I. scapularis-borne human infections
human vaccines or prophylactic antibody treatments
Lyme disease spirochetes
I. scapularis-borne pathogens
transmission-blocking anti-tick vaccines
I. scapularis-borne pathogens
vaccine against Bo. burgdorferi
prophylactic antibody treatment
Lyme disease
I. scapularis-borne pathogens
transmission-blocking anti-tick vaccine
pathogen transmission
I. scapularis-borne infections
nonpolio enteroviruses
meningitis
pathogen concentration in CSF
standard microbiologic stains
Mycobacterium tuberculosis
Listeria monocytogenes
Cryptococcus neoformans
meningitis
CSF
human immuno-deficiency virus
HIV
Lyme disease
syphilis
parameningeal focal processes
brain tumor
brain or paraspinal abscess
transverse myelitis
herpes simplex encephalitis
clinical syndrome
Aseptic meningitis
viral meningitis
polymerase chain reaction assays
enteroviral ribonucleic acid
cytokine levels
interleukin-1
tumor necrosis factor
CSF
distinguish viral from bacterial meningitis are important
enigmatic meningitis
acute meningitis with a negative CSF Gram's stain
enigmatic meningitis
acute meningitis with a Gram's stain negative for bacteria
enigmatic meningitis
non-Hodgkin’s B cell CNS lymphoma
chemotherapeutic doses of methotrexate
MTX
MTX infusions
CNS lymphoma
lesions
brain MRI scan
MTX
brain lesions
high-dose MTX
rituximab
temozolomide
myeloablative chemotherapy consisting of cytarabine
blood pressure
respiratory rate
room air oxygen saturation
mucous membranes
oral lesions
nontender temporal arteries
lymphadenopathy
cervical
supraclavicular
axillary
abdominal
inguinal sites
right-sided internal jugular venous-access catheter
subclavian or carotid bruits
nailbed capillaries
rash
Cranial nerve V
cranial nerves VII–XII
deep tendon reflexes
plantar responses were flexor
Lyme carditis
Lyme disease
stage 2 of the B burgdorferi infection
neurologic symptoms
musculoskeletal symptoms
erythema migrans lesion
erythematous rash
erythema migrans lesion
Lyme carditis
syncope
dyspnea
palpitations
chest pain
B burgdorferi infections
pericarditis
endocarditis
myocarditis
pericardial effusion
myocardial infarction
coronary artery aneurysm
prolonged QT interval
congestive heart failure
antibiotics
LM
CSF
cerebrospinal fluid
.8 white blood cells
erythema migrans
EM
Lyme serology
Serologic tests
Borrelia burgdorferi
positive western blot test
Lyme disease
western blotting
enzyme immunoassays
VM
CSF
viral infection
positive CSF
nasopharyngeal
rectal cultures
poliovirus in rectal cultures
meningitis
Aseptic meningitis
meningeal inflammation
CSF
meningitis
Transverse myelitis
malignancy
syphilis
bacteremia
Lyme disease
viral meningoencephalitis
viral agents
Coxsackie and echoviruses
aseptic meningitis
Lyme disease
vector-borne infection
Lyme disease
endemic areas
Lyme neuroborreliosis
LM
VM
provide effective therapy
LM
antibiotic treatment
VM
VM
LM
CSF pleocytosis
EM
positive serologic tests
enzyme immunoassay
western blot tests
nervous system
LM
antibody
Borrelia burgdorferi DNA
polymerase chain reaction
polymerase chain reaction test
fever
rash
infectious disease
neurological examination
cranial nerve functions
meningitis
bilateral cerebellar signs
dysarthria
nystagmus
bilateral dysmetria
intention tremor
marked ataxia
Superficial and deep tendon reflexes
blood leukocyte coun
serum C-reactive protein
erythrocyte sedimentation rate
computed tomography
CT
magnetic resonance imaging
MRI
brain
Cerebrospinal fluid
CSF
mild pleocytosis
Acyclovir
cefotaxime
clarithromycin
herpes simplex virus
cytomegalovirus
varicella zoster
mumps
rubella
rubeola
Epstein-Barr virus
mycoplasma
Intravenous immunoglobulin
IVIG
postviral immune response
acute cerebellar ataxia
Borrelia burgdorferi
pathogen-specific IgM
IgG
rash
Acyclovir
clarithromycin
intravenous cefotaxime
CSF Lyme serology
neurologic examination
B. burgdorferi IgM and IgG antibodies
IgG
acute febrile illness
infectious diseases
varicella-zoster
Epstein-Barr
entero-virus
rubeola
parvovirus
mycoplasma infections
Varicella
infectious agents
pathogenesis of ataxia
autoimmune mechanism
Antiviral antibodies and autoreactive antibodies targeting cerebellar neurons
autoantibodies
centrosome protein pericentrin
CSF
viral nucleic acids
CSF
pathogen
central nervous system
cerebritis
acute demyelinating encephalomyelitis
Lyme disease
acute cerebellar ataxia
Lyme disease
fever
malaise
severe left arm radicular pain
intravenous fluids
right-sided neck pain
headache
tinnitus
otalgia
subjective hearing loss
lower facial muscle weakness
erythema chronicum migrans
arthralgias
arthritis
Bell’s Palsy
Lyme disease
herpes simplex virus 1 and 2
Epstein-Barr virus
doxy-cycline
positive Lyme antibody test
pediatric neuroborreliosis
CN VII palsy
lymphocytic meningitis
neuroborreliosis
CN VII palsy
CNs III
CNs
MR
right-sided CNs VII and VIII
right CN III
CN V
CNs
MRI
pediatric cases of neuroborreliosis
pediatric neuroborreliosis
right-sided CN VI palsy
MRI
CN VI bilaterally
CN III ipsilaterally
thalamic lesions
CN inflammation
NorthAmerican neuroborreliosis
Bell’s palsy
unilateral facial paralysis
unilateral facial paralysis
Bell’s palsy
partial or complete weakness of the muscles of half of the face
hyperacusis
Bell’s palsy
facial nerve
geniculate ganglion
ischemia
demyelination
herpes simplex virus type 1
Bell’s palsy
corticosteroids
antiviral medications
ndex ED
ED encounters
ED
index ED Bell’s palsy diagnosis
ischemic stroke
intracranial hemorrhage
subarachnoid hemorrhage
brain tumor
central nervous system infection
meningitis
encephalitis
brain abscess
Guillain-Barré syndrome
Lyme disease
otitis media
mastoiditis
herpes zoster
Bell’s palsy
diabetic neuropathy
sarcoidosis
Bell’s palsy
diabetes mellitus
CT
MRI imaging
Bell’s palsy
ischemic stroke
herpes zoster
Guillain-Barré syndrome
otitis media
Bell’s palsy
Guillain-Barré syndrome
Guillain-Barré syndrome
heterogeneous immune-mediated neuropathies
progressive and symmetric motor weakness
deep tendon reflexes
Guillain-Barré syndrome
acute inflammatory demyelinating polyneuropathy
ascending paralysis
Guillain-Barré syndrome
cranial nerves
Miller Fisher syndrome
ophthalmoplegia
ataxia
areflexia
Miller Fisher syndrome
Guillain-Barré syndrome
cranial nerve abnormalities
Guillain-Barré syndrome
Miller Fisher syndrome
Bickerstaff encephalitis
pharyngeal-cervical-brachial weakness
Bell’s palsy
ED misdiagnosis of Bell’s palsy
Guillain-Barré syndrome
Lyme disease
erythema migrans
Lyme disease
ELISA
positive Western blot serology
positive IgG Western blot
Lyme disease
IV ceftriaxone
Lyme disease
Wechsler Memory Scale
IV antibiotic therapy
neurologic Lyme disease
intent-to-treat
ITT
Lyme patient
IV antibiotic
IV placebo
ongitudinal mixed-effects models
LMM
LMM
Bayesian information
ITT differences
lumbar puncture
WBC
gammaglobulin
Lyme ELISA,
IgG WB
IgM WB
intrathecal Ab production
positive intrathecal sample
seropositive
CSF PCR
spirochetes
cells’s DNA
PCR amplification
spoT gene
PCR amplicon
agarose gel electrophoresis
PCR amplicon from wild-type strains
B burgdorferi
CSF culture
BSKII
kanamycin
streptomycin
B burgdorferi strain
CSF culture
spoT mutant strain
WC07
B burgdorferi
spoT gene
streptomycin resistance gene
spoT mutant strains
thrombus
staphylococcal infection
narcotic pain medication
cholecystectomy
PICC line or medication
IV ceftriaxone
IV placebo
IV ceftriaxone
ceftriaxone group
posttreatment Lyme disease
IV ceftriaxone
IV ceftriaxone
antibiotic
neurologic abnormalities
ceftriaxone
B. burgdorferi
Lyme antigen source
Spirochetes
proteins
Nova blot semidry transfer system
nitrocellulose membranes
polyacrylamide gels
bovine serum albumin in PBS
IgG and IgM antibodies to B. burgdorferi antigens
biotinylated antiserum
goat anti-human IgG γ chain specific
IgM m chain specific
Peroxidase-conjugated streptavidin
Lyme disease
ELISA
enzyme-linked immunosorbent assay
ELISA
Western blot
Lyme disease
Bell palsy
Lyme disease
central nervous system
ceftriaxone
oxycycline
Western blot
doxycycline
Lyme disease
facial palsies
B burgdorferi
peridomestic risk factors
I scapularis ticks
B burgdorferi
I ricinus ticks
B afzelii
Lyme disease
endemic and nonendemic areas
nonendemic states
nonendemic areas
nonendemic areas
